Meet our Ambassadors 151- …

Anjuli Borgonha is an AMR Communication Specialist working at the The Food and Agriculture Organization of the United Nations. In 2019 Anjuli completed a Masters thesis in social change communications examining antibiotic resistance communications campaigns. Anjuli has a background in communicating complex health and development issues and previously worked at the Lancet Countdown on Health and Climate Change where she led a campaign on the impacts of our changing climate on human health. She is interested in how best to communicate the complexities of antimicrobial resistance to the public and encourage widespread action and behaviour change. She wants to contribute her communications expertise to tackling AMR, recognising an urgent need to increase public understanding of this major issue.

Arnab Sinha is the Managing Director at Novonanmek Material Sciences Private Limited in India. Keeping in mind the issue of Antimicrobial Resistance, Arnab developed a Nano Zinc Oxide based coating called BIOZINY, that has the ability to Eliminate resistant bacteria from surfaces. The coating might find applications in Health Care centres and Hospitals to protect people from Healthcare Acquired Infections (HAIs). The coating can be used in all public places – like Schools, Offices, Malls, Supermarkets, Railway Stations, Airports and many other to protect surfaces from Resistant Bacteria. The company is continuously working to develop better coatings to fight resistant bacteria. Arnab is a Mechanical Engineer and also holds an M.S. in Material Science and Engineering from Indian Insitute of Engineering Science and Technology, India.

John Addotey is a senior lecturer at the Faculty of Pharmacy and Pharmaceutical Sciences, KNUST, Ghana.  John teaches various courses in Pharmaceutical and Medicinal Chemistry to undergraduate and Postgraduate students. His research focus has been quality control and method development for the analysis of pharmaceuticals mainly, antibiotics. He is also into stability studies of antibiotics in local storage simulations. The conditions of storage affects the efficacy of antibiotics and could be a source of AMR in Ghana. John has in the past been involved in the harmonization of regulatory laboratories in the West Africa Health Organization. He has been the Quality Control co–ordinator of the Department of Pharmaceutical Chemistry where he consulted for the Ghana FDA with regards to quality control of medicines including antimicrobial agents.

Abdulrazak Lawal is building technology solutions to promote AMR stewardship in Cardium, Nigeria. Abdulrazak is a pharmacist, co-founder, and CEO of Cardium in Nigeria. His company Cardium is developing a mobile app that improves health literacy and promoting AMR stewardship for non-medical professionals(patients). More than 80 percent of drug consumers in Nigeria do not use medication reminder app either because they are not aware of such an app or were not recommended for them by their healthcare provider. Their poor health literacy leads to the irrational use of medicine including antimicrobial agents. Cardium is designed to be the most suitable medication management app for non-medical professionals with special attention on anti-infective in awareness, the danger of misuse, and preventive measures. The company believes that AMR stewardship is as important as developing new antimicrobial agents and pharmacotherapy is an anchor to access and communicate with the patient.

Linda Bergsten is an Environmental consultant with pharmaceutical experience and working at Suspire GmbH in Switzerland. Linda has over 20 years experience in developing strategies and programs to reduce the environmental impact of businesses, predominantly in the pharmaceutical and logistics industry. She has worked with health, safety and environmental topics for pharmaceutical and antibiotic outsourcing and manufacturing and has a background in industrial wastewater treatment. She is passionate about minimizing the pollution from antibiotic manufacturing to prevent AMR.

Rebecca McDonald is the Head of Bacteriology at Vast Therapeutics, Inc. in the United States. Vast Therapeutics is a development-stage antimicrobial company in Durham, North Carolina. Their approach is to use natural, biodegradable polymers to deliver nitric oxide directly to the site of infection for a variety of clinical areas including lung infections, gastrointestinal infections, and skin and soft tissue infections. Personally, Rebecca is responsible for designing and conducting in-house microbiological testing and for liaising with CROs and academic partners to evaluate proof-of-concept by testing the lead candidates in animal models of infection.

Clara Ballesté-Delpierre is Coordinator at the Antimicrobial Resistance Initiative (ISGlobal) and Associated researcher at ISGlobal in Spain. Clara is Associated Researcher and Coordinator of the ISGlobal’s Antimicrobial Resistance Initiative based in Barcelona (Spain). The AMR Initiative is designed to help to fight the growing emergence and spread of pathogens resistant to antimicrobial drugs from a multidisciplinary approach through the institute’s core activities: research, training, technical assistance and analysis.

Katrien van’t Hooft is the Director Dutch Farm Experience and coordinator Natural Livestock Farming network in The Netherlands. Katrien is a Dutch veterinary doctor. After 25 years of fieldwork in various parts of the world she founded Dutch Farm Experience (http://www.dutchfarmexperience.com) in 2011. This company connects international groups to the most innovative and sustainable (dairy) farmers within the Netherlands. Between 2014-2017 Dutch Farm Experience headed the successful exchange program between Netherlands and India, Ethiopia and Uganda, providing alternatives for the use of antibiotics and other chemicals in dairy farming to improve milk quality. Since 2015 this is organized as the Foundation for Natural Livestock Farming (NLF), which counts with platforms in four countries. This network is spearheading the NLF 5-layer strategy to minimize the use of antibiotics and other chemicals in dairy farming as a One Health approach. This includes the use of medicinal plants and strategic use of local cattle breeds.

Jenipher Asiimwe is a Journalist working at Uganda Broadcasting Corporation in Uganda. Jenipher is a passionate climate change, gender,environment, water, sanitation and hygiene journalist and a 2020 CAPOOP and 2019 RNTC media fellow. Besides broadcasting and writing at Uganda Broadcasting Corporation and Africa Brief respectively, she has partnered with other regional and international media outlets and other entities to produce, write and publish news stories on matters of public interest in Africa. These among others include, RNW (The Netherlands), Down To Earth (India), AMR Insights (The Netherlands), Federal Radio Corporation (Nigeria) and CapiTalk (Zimbabwe).

Bas Maier is a Network Manager Sustainable Healthcare Netherlands at MVO Nederland in The Netherlands. As the Sustainable Healthcare Networkmanager in the Netherlands, Bas is responsible for the realisation of several healthcare pilots in the Netherlands. Thier total network consists of 2000 participants and their healthcare network includes around 40 organisations. MVO Netherlands works across industries. At the moment Bas is launching an AMR pilot in The Netherlands together with pharmacy partners, the Dutch Government and health insurance companies.

Maneesh Paul is Director R&D at Acharya Institutes & Orchid Pharma
in India. Maneesh is the Co-inventor of the antibiotic Enmetazobactam.
Trained as a Clinical microbiologist from Kasturba Medical College Mangaluru, with a doctorate from Gnanaganga. Maneesh did postdoctoral education specialising in pathogenesis of infectious diseases from Johns Hopkins School of Medicine, Baltimore USA, and from Umeå University in Sweden. He worked at the Center for Biologics Evaluation & Research US-FDA, USA in meningococcal vaccines. Maneesh returned to India to the lead Antimicrobial New Drug Discovery at Orchid Pharma in Chennai. He became the Antimicrobial Resistance (AMR) champion in 2008 and is the member of Infectious Diseases Society of America’s AMR Committee (USA). Maneesh is presently the Director of R&D leading trans-disciplinary research in Acharya group of Institutions.

Ibrahima Kouma is a Vetenary technician at the Ministère des Ressources Animales et Halieutiques, Côte d’Ivoire. Ibrahima is the founder of Healthcare Communications and Social Media in Côte d´Ivoire is a section of Hcsmafrica – Healthcare Communications and Social Media Africa. It’s a virtual platform (for now) that is trying to create an environment conducive to improving the public health system in Côte d’Ivoire and Africa. Ibrahima is also the Head of the Veterinary Control and Food Hygiene Service of Satama-Sokoro. He is a veterinary technician passionate about the fight against AMR and AMU. Ibrahima firmly believes that we can reduce the negative influence of AMR on public health, it only takes willpower and good communication strategies.

Clare Phillips is the Founder and Director of Pure Ingenious Ltd t/a Ingenious Probiotics in the United Kingdom. Clare is a former Nursing Sister and co-founder of Ingenious Probiotics in the UK. She believes education and changing chemical cleaning and antibiotic animal care practices at ‘ground level’ is needed to reduce AMR. Clare is introducing chemical-free, probiotic-based animal care and cleaning products to the UK that work in a safe, natural and mechanical way and do not cause antibiotic resistance. As a result, a vet is now successfully treating animal wounds, bacterial ear and eye infections with probiotic-based preparations and no antibiotics – or with a significantly reduced dose. This will be rolled out to farm – cattle, sheep, pigs – and equestrian vets. The cleaning products are eco-detergents made with non-mutative strains of probiotic bacteria that do not develop resistance. Clare believes that increasing understanding and changing habits and practices at this ‘hands on’ level has the potential to significantly reduce AMR and protect the next generation.

Leonard Uzairue is a Medical Laboratory Scientist/Doctoral Student at the International Foundation Against Infectious disease in Nigeria/Federal University of Agriculture Abeokuta, Ogun State Nigeria. Leonard Ighodalo is a Medical Laboratory Scientist, public health scientist with over 9 years of experience spanning Medical laboratory and public health at public institutions (Irrua specialist Hospital, Irrua, Edo State, National Hospital, Abuja and University Medical Centre, Federal University, Oye, Oye-Ekiti) and presently a Medical Laboratory Scientist and Quality officer at International Foundation Against Infectious Disease In Nigeria (IFAIN), one of the consortia of the Fleming fund in Nigeria. As a Youth leader in his community, he has been involved with awareness about AMR and danger of misuse of antibiotics. His passion for antimicrobial resistance led Leonard to focus his MSc research on using genomics to understand the epidemiological relationship between antimicrobial resistance in bacterial pathogens from Human and Environment. Currently, Leonard is a Doctoral student at Department of Microbiology, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria. His proposed research is focused on genomic epidemiology of AMR.

Chioma Achi is a Doctoral Researcher at the University of Cambridge in the United Kingdom. Chioma is a veterinarian by training with an advanced degree in Applied Microbiology, Biotechnology, and Veterinary Public Health. Her current research focuses on One-Health and seeks to answer questions on the evidence of transmission of antimicrobial resistance in Salmonella isolates recovered from people, animals and the environment. Her broad research interests are in the area of bacterial genomics, AMR in zoonotic pathogens, and food safety. Chioma is also interested in science communication on AMR and an advocate for antimicrobial stewardship.

Phil Packer is the Innovation Lead, AMR and Vaccines, at Innovate UK in the United Kingdom. Phil leads on Antimicrobial Resistance (AMR) and Vaccines at Innovate UK, developing & delivering funding calls, supporting workshops and strategy. This includes overseeing extant and new projects funded through IUK funding mechanisms such as the Biomedical Catalyst and SMART call. In addition, he is responsible for the delivery of the following projects focused relating to AMR and Vaccines: China-UK AMR call, AMR in Humans and Various Vaccine calls. His areas of Interest include the One Health approach to addressing AMR holding therapeutic & prophylactic solutions, new diagnostics, solutions in the Agri-food sector and solutions in Infection, Prevention & Control.

Nidhi Patel works as a scientist at PreviPharma Consulting GmbH, Mannheim, Germany. Her main research objective at the company is to combat AMR using patient ‘s own innate immunity arm in combination with antibiotics. Nidhi has a strong background in system and quantitative biology. Since the last few years she is working on AMR in industry as well in academic set up in different countries. Nidhi has organised some outreach program based on AMR awareness and behaviour change through games. Her contribution towards curbing AMR is not only through research activities but also involving herself in various social aspects such delivering seminars on importance of use and misuse of antibiotics (under education program), awareness programs, sharing and spreading the knowledge of experts through social media to reach out common man.

Chandanamali Punchihewa is the Chief Scientist at Genelabs Medical (Pvt) Ltd in Sri Lanka. Chandanamali is a molecular geneticist involved in molecular diagnostics. She has been carrying out molecular microbiology testing over the past 6 years, and has validated and offered several tests for antimicrobial resistance. She is currently more involved in Next Generation Sequencing-based tests, and would like to develop/offer NGS tests for microbial detection and AMR evaluation.

Pamela Barbadoro is Associate Professor-Infection Control Physician at the Università Politecnica delle Marche, Ancona, Italy. Pamela is a Medical Doctor with a residency in Hygiene and Preventive Medicine. She works as an Infection Control Physician at the Ancona teaching hospital with a focus on AMR surveillance, antibiotic-stewardship and surveillance and prevention of healthcare associated infections. Pamela is the co-coordinator of the Regional surveillance systems for antimicrobial resistance and healthcare-associated infections.

Afsana Sabrin is a Postdoctoral Reserach Fellow and Senator at the Albert Einstein College of Medicine, United States of America. As a scientist her research interest is to contribute to development of early and late-stage therapeutics to make a big impact on multiple diseases with high unmet potential. Afsana is a Postdoctoral Research Fellow at Albert Einstein College of Medicine, NY, USA. She is serving as Senator at Einstein Senate. Her current research is focused on developing inhibitor molecules of specific glycosyl transferase that are potential anti-cancer drugs. She has completed her PhD at Louisiana State University, LA, USA. Her PhD dissertation shed light on the transcriptional regulation of major multidrug transporters in lethal bacteria. Afsana characterized a novel oxidant-sensing transcriptional regulator, OstR, as a potential bacterial drug-target. She discovered gentamicin can induce expression of a major multidrug transporters in bacteria to efflux out structurally diverse antibiotics. Her PhD research documents important details to modify current antibiotics or develop novel therapeutics against lethal multi drug resistant bacterial infections.

Emmanuel Benyeogor is the AMR Surveillance and Coordination Assistant at the Nigeria Centre for Disease Control in Nigeria. Emmanuel is a data scientist and epidemiologist by training. He works as a coordination assistant at the Nigeria Centre for Disease Control and support on data management and surveillance in the National AMR Technical Working Group. He is currently an AMR surveillance Fleming Fund fellow in Nigeria with Denmark Technical University as his host institution and a ProMED AMR moderator for Africa. For Emmanuel, using data to inform policy and drive action is at the crux of what fuels his motivation. Emmanuel is building capacity in the field of whole genome sequencing and metagenomics, in his recent proposal to understand the local burden of AMR in Nigeria with a correlation of socio-economic and health factors. He hopes to learn about possible AMR transfer from mothers to their under-fives. He is currently working on developing an Antimicrobial Resistance and Use alert system using a one health approach for surveillance.

Luigia Scudeller is a Clinical Epidemiologist and Infectious Diseases physician in Italy. Luigia is very interested in education and training of young researchers in biomedical and clinical research methods, with an overall goal of improving research conduct and reporting. Since 2018 she is Medical Guideline Director of the European Society of Clinical Microbiology and Infectious Diseases. She coordinates the GAP-ON€ network, which aims at deriving a framework for the full One Health estimates of AMR in a global perspective. The network includes human and veterinary clinicians, human and veterinary microbiologists, experts in antimicrobial resistance burden, food safety, health-economics, and international law, as well as infection control experts, clinical epidemiologists, statisticians, and health information librarians.

Geethani Galagoda is the administrative head of a hospital laboratory with a laboratory network outside the hospital. Geethani is also the virologist in charge of the serology laboratory at Lanka Hospitals Diagnostics (LHD) in Sri Lanka. Geethani joined LHD as the Head of Laboratories in August 2016. She completed her MBBS in 1987 and post graduate MD in Medical Microbiology in 2000. Her 1 year post-graduate training was at the Centre for Disease Control and Prevention (CDC) in the USA. She was a virologist at the Medical Research Institute (MRI) where she was head of the Measles and Rubella, Rotavirus and Japanese Encephalitis National Laboratories and Hepatitis Laboratory. She has several publications in peer reviewed journals and has many scientific presentations. Geethani also has conducted many workshops in the field of virology. She is a post graduate medical teacher in the fields of Microbiology, Virology, Pathology, Venereology and Transfusion Medicine. She has been the Secretary of the Research and Ethics Review Committees of the MRI for 5 years. Also Geethani has been the editor of the SLMA Guidelines and Information on Vaccines, in 2017 and 2019.

Vindana Chibabhai is a Clinical Microbiologist at Charlotte Maxeke Johannesburg Academic Hospital Clinical Microbiology Laboratory (National Health Laboratory Services) in South AfricaShe knows that raising awareness of AMR is central to improving antimicrobial use. She recognises that much work needs to be done to understanding and preventing AMR. Vindana believes that improved diagnostics, stewardship and research can improve antimicrobial use. Vindana’ s interests include the epidemiology, diagnosis, and management of multidrug resistant infections (bacterial and fungal) and implementation of novel stewardship strategies. She is involved in AMR and stewardship related activities and has co-authored several articles on AMR in peer-reviewed journals. Vindana is also a lecturer in the Department of Clinical Microbiology and Infectious Diseases at the University of the Witwatersrand (Wits). Vindana holds an MBBCh and a Masters of Medicine in Clinical Microbiology from Wits and an FCPath in Clinical Microbiology from the Colleges of Medicine SA.

Herman Barkema is Professor in Epidemiology of Infectious Diseases at the University of Calgary in Canada. Herman completed his DVM degree at Utrecht University in The Netherlands. He spent 2½ years as manager of a large dairy and beef herd in Costa Rica, then taught bovine herd health at Utrecht University, and worked as an epidemiologist for the Dutch Animal Health Service while completing his PhD. He currently is Professor in Epidemiology of Infectious Diseases at the Faculty of Veterinary Medicine of the University of Calgary, with a joint appointment in the Cumming School of Medicine. He is also a Foreign Expert at the China Agricultural University. Herman’s research program focuses on prevention and control of diseases in cattle herds, including antimicrobial resistance. He has published >325 scientific manuscripts and has lectured all over the world. He leads the UCalgary Biostatistics Centre, One Health @ UCalgary, the Environment research theme in the Mastitis Network, the Alberta Johne’s Disease Initiative and the AMR – One Health Consortium.

Anita E. Asamoah is a Public Health Epidemiologist working at the University of Ghana in Ghana. As a public health epidemiologist Anita is interested in combating AMR in any form she can, education in rural communities and research. Anita is a post graduate of University of Ghana. Her recent research is on factors associated with antimicrobial self-medication in eastern region of Ghana in rural communities. Respondents were found to prefer antimicrobial self medication rather then to visit health facilities.

Chidozie Declan Iwu is an Antimicrobial resistance ambassador studying at the University of Pretoria, South Africa. Chidozie Declan is a Microbiologist and a public health enthusiast. He was part of the concluded project on the Characterization and source tracking of antimicrobial resistance within the plant-food-water-public health nexus in the Eastern Cape Province of South Africa. His research interests are on infectious disease control, surveillance and outbreak preparedness/investigations with a concurrent focus on antimicrobial resistance stewardship using the one-health approach. Research in the area of vaccine-preventable disease epidemiology in low and middle-income countries also interests him.

Oluwatosin Akinwotu is an environmental Microbiology Researcher working at the Combat Antimicrobial Resistance Initiative (CARI-X) in Nigeria. Oluwatosin is a PhD researcher in Microbiology, University of Ibadan, Nigeria, with over 8 years experience in Antibiotics Resistance-related research. He is currently focusing on Antibiotics resistant Enterobacteriaceae in selected wetlands in Nigeria. He is the founder of Combat Antimicrobial Resistance Initiative (CARI-X), an establishment on the mission to strengthen the global war against AMR by engaging in AMR Stewardship using “One Health” approach. He is a OneHealth Advocacy and Mentorship (OHAM) Fellow, demonstrating quality leadership in coordinating and training cohorts of young and smart professionals in various areas to mitigate the continuous proliferation of AMR and “Superbugs” in Nigeria. Oluwatosin also joins other youth organizations to engage in regular Infection Prevention and Control (IPC) Sensitation programs.

Stephen Hawser is the CEO at IHMA Europe in Switzerland. His primary interest being R & D of new therapies to combat AMR and running surveillance studies to monitor and help combat AMR, Stephen has 25 years of anti-infective industrial experience and is CEO of IHMA Europe Sàrl since 2009. IHMA Europe has state-of-the-art laboratories and is based in Monthey, Switzerland. Prior to joining IHMA, Stephen held several key positions in the pharmaceutical industry spanning around 15 years with focus in antibacterial and antifungal research and development. His industry experience has come with his affiliations with Arpida (Switzerland), GlaxoWellcome (Italy), Hoechst Marion Roussel (France) and Marion Merrell Dow (Italy) and secondments to Hoechst (Frankfurt, Germany and Mumbai, India) and to University Hospitals / CWRU (Cleveland, OH, USA). He regularly publishes in peer-reviewed journals manuscripts on surveillance and resistance and always welcomes opportunities to share ideas and work together.

Osama Madni is a Master student at the University of KwaZulu-Natal in South Africa. The aim of his research study is to delineate the molecular epidemiology of carbapenem-resistant Enterobacterales (CREs) colonizing patients in intensive care units in public and private hospitals in the Mgungundlovu District. His current/anticipated commitment to combat Antimicrobial resistance: Participating in to enrich our knowledge in this topic will insinuate scientist communities forward to developing new generations of antibiotics, furthermore, encouraging national and international decision-makers at healthcare systems to undertake policies for Carbapenems use.

Nicole Hackman is an associate professor of pediatrics at Penn State College of Medicine, Pennsylvania, USA. She is a co-founder of the Pennsylvania Consortium for Antibiotic Stewardship (PCAS), a multi-specialty organization dedicated toward antibiotic stewardship education and research through collaboration. Nicole participated in several research projects exploring the role of provider education in the use of watchful waiting for pediatric acute otitis media, and is currently developing an outpatient antibiotic stewardship program for her health system. She is an active clinician, educator and researcher.

Abigail  Herron is Global Head of responsible investment at Aviva Investors in the UK. Abigail is a leader and ambassador for sustainable investment within Aviva Investors and externally, working closely with the investment teams as well as directly with clients and engaging with investee companies, NGOs and public policy makers across the spectrum of environmental, social and governance topics. She has a special interest in the role investors can play in tackling AMR and is the co-founder of the Superbugs and Super Risks series of events and reports. Abigail recently completed a Masters in antibiotic resistance at the University of Cambridge.

Thulasiraman, P is an Assistant Professor at Banaras Hindu University, Varanasi in India. He is working as Assistant Professor in Veterinary Physiology in the Faculty of Veterinary and Animal Sciences. He is in favor of curtailing AMR due to its devastating nature. He did his Doctoral research on AMR (Antibiotic Resistance Pattern Mapping in Bovine Mastitis milk) from ICAR-National Dairy Research Institute, India.

Ifeoluwa Akanni is a pharmacist, public health consultant with over three decades of experience spanning private, clinical and public health. Currently she is a PhD student at ABU Zaria in Nigeria. In the community, she has been involved in educating clients visiting the community pharmacy on rational antibiotic use and as a hospital pharmacist, was a member of the infection control team, where she created awareness among colleagues and other health professionals on importance of effective antimicrobial stewardship. Her passion for antimicrobial resistance led her to carry out a research on antimalarial drug resistance. As part of her ongoing PhD program, she is currently working on a research on antibiotic resistance in chronic wounds infections with particular focus on S. aureus in immuno-compromised patients.

Charles Lam is a Medical Microbiologist with a strong commercial acumen. He works with the EU and UNIDO as a Senior Monitoring and Evaluation Expert. He also has >30 years of hands on drug R&D—from the bench to the bedside working for a big pharma. He is experienced in the qualitative and quantitative use of real world data for the synthesis of epidemiological real world evidence on the burden and costs of infectious diseases. His motivation to join is based on the concept of One Health as a potential framework to understand the ‘wicked problems’ caused by AMR. Solutions to AMR require a highly coordinated and carefully led process by multi-sector and inter-disciplinary collaborative approaches for change that every stakeholder can accept. With over 30 years’ experience working in a big pharma, Charles has a clear role to contribute to tackling the wicked problems of AMR.

Jonathan Asante is a PhD student at the Antimicrobial Research Unit, University of KwaZulu Natal in South Africa. Jonathan is a pharmacist and a member of the Pharmaceutical Society of Ghana, with experience in hospital and community pharmacy practice. In pharmacy practice, he has been worked closely with other health professionals to ensure better treatment outcomes for patients and responsible use of antimicrobials. He is currently a PhD candidate at the Antimicrobial Research Unit, University of KwaZulu Natal, South Africa. His project focuses on antimicrobial resistance and resistance determinants in bacteria from clinical and food animal sources. His Master’s research focused on the molecular characterization of methicillin-resistant Staphylococcus aureus isolates from a hospital in Ghana. Passionate about antimicrobial resistance (AMR), he is determined to contribute his part through research to stem the tide of AMR. He has research published in peer-reviewed journals

Andrea Gori is Professor of Infectious Diseases at the Università degli Studi di Milano in Italy. He is head of the Infectious Diseases Unit at Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico. Andrea works in the immunopathogenesis of viral and bacterial infections and in mechanisms of interaction between the pathogens and the host focusing in how to translate information learned from pathogenetic studies into the clinic. His research activities focuses on human T cell phenotypic and functional analysis, T cell activation, and in the mechanisms of immune reconstitution and microbiota interaction. He directs several research programs dedicated to the investigation of the immunopathogenesis of antiretroviral-treated HIV infection. Andrea is involved in educational projects on antimicrobial stewardship developing a significant experience in managing epidemiological and clinical aspect of AMR infections. As a PI he has performed numerous studies participating in international projects to improve the quality of care for patients affected by infectious diseases. He has published over 200 peer-reviewed articles

Krunal Dholiya is Co-founder at Framtix Holdings AB in Sweden. His company Framtix holdings ab is developing various antimicrobial materials and coating. Krunal is Assistant Professor at VNSGU, Surat. Since last many years, he has been working on Antimicrobial compounds and on the development of resistance against them. Currently, he is conducting research on the application of bacterial spores against AMR.

Achim Hoerauf is the Director and Chair, Institute for Medical Microbiology at the University Bonn Medical Center in Germany. Achim is a Full Professor of Microbiology and Parasitology and Director of the above Institute. It is the central Infectious Diseases lab of the medical center, processing more than 120,000 samples per year. Since 2013, he has been coordinator of the German Ministry for Research funded German Center for Infection Research (DZIF) in Bonn-Cologne. Since May 2017, he is chairman of the German Network against Neglected Tropical Diseases in Germany (www. DNTDs.de). Achim is known for his work in Tropical Medicine, specifically, for pioneering a new treatment for filariasis (a group of NTDs), which exploits the symbiosis between filariae and bacterial endosymbionts called Wolbachia. This discovery has sparked development of macrofilaricidal research programmes by the Gates Foundation and DNDi. His group also found the natural compound Corallopyronin A to be an antibiotic active against human filariasis and heartworm disease, as well as against Staph aureus and Gonococci and Chlamydiae.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!